Clinical Trial Update: Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing omadacycline to linezolid for acute bacterial skin and skin structure infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Skin and Soft Tissue Infection

Drugs mentioned

• Linezolid (Linezolid)
• Omadacycline (omadacycline)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Bacterial Infections, Skin Structures and Soft Tissue Infections | Phase 3 | Status: COMPLETED | Results posted: 2019-03-21